OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Understanding the components of pharmaceutical expenditure—overview of pharmaceutical policies influencing expenditure across European countries
Sabine Vogler, Nina Zimmermann, Claudia Habl
Generics and Biosimilars Initiative Journal (2013) Vol. 2, Iss. 4, pp. 178-187
Open Access | Times Cited: 19
Sabine Vogler, Nina Zimmermann, Claudia Habl
Generics and Biosimilars Initiative Journal (2013) Vol. 2, Iss. 4, pp. 178-187
Open Access | Times Cited: 19
Showing 19 citing articles:
ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
Nathan I. Cherny, Richard Sullivan, Julie Torode, et al.
Annals of Oncology (2016) Vol. 27, Iss. 8, pp. 1423-1443
Open Access | Times Cited: 153
Nathan I. Cherny, Richard Sullivan, Julie Torode, et al.
Annals of Oncology (2016) Vol. 27, Iss. 8, pp. 1423-1443
Open Access | Times Cited: 153
Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries
Sabine Vogler, Katharina Habimana, Danielle Arts
Health Policy (2014) Vol. 117, Iss. 3, pp. 311-327
Closed Access | Times Cited: 64
Sabine Vogler, Katharina Habimana, Danielle Arts
Health Policy (2014) Vol. 117, Iss. 3, pp. 311-327
Closed Access | Times Cited: 64
Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan
Muhammad Rehan Sarwar, Sadia Iftikhar, Anum Saqib
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Muhammad Rehan Sarwar, Sadia Iftikhar, Anum Saqib
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Prescribing efficiency of proton pump inhibitors in China: influence and future directions
Wenjie Zeng, Alexander Finlayson, Sushma Shankar, et al.
BMC Health Services Research (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Wenjie Zeng, Alexander Finlayson, Sushma Shankar, et al.
BMC Health Services Research (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 48
A systematic review of pharmaceutical pricing policies in developing countries
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim, Zaheer‐Ud‐Din Babar, et al.
Journal of Pharmaceutical Health Services Research (2017) Vol. 8, Iss. 4, pp. 213-226
Closed Access | Times Cited: 30
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim, Zaheer‐Ud‐Din Babar, et al.
Journal of Pharmaceutical Health Services Research (2017) Vol. 8, Iss. 4, pp. 213-226
Closed Access | Times Cited: 30
Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan
Anum Saqib, Sadia Iftikhar, Muhammad Rehan Sarwar
BMJ Open (2018) Vol. 8, Iss. 6, pp. e019015-e019015
Open Access | Times Cited: 24
Anum Saqib, Sadia Iftikhar, Muhammad Rehan Sarwar
BMJ Open (2018) Vol. 8, Iss. 6, pp. e019015-e019015
Open Access | Times Cited: 24
Pricing of HPV vaccines in European tender-based settings
Venetia Qendri, Johannes A. Bogaards, Johannes Berkhof
The European Journal of Health Economics (2018) Vol. 20, Iss. 2, pp. 271-280
Open Access | Times Cited: 21
Venetia Qendri, Johannes A. Bogaards, Johannes Berkhof
The European Journal of Health Economics (2018) Vol. 20, Iss. 2, pp. 271-280
Open Access | Times Cited: 21
Review of studies reporting actual prices for medicines
Nika Marđetko, Mitja Kos, Sabine Vogler
Expert Review of Pharmacoeconomics & Outcomes Research (2018) Vol. 19, Iss. 2, pp. 159-179
Closed Access | Times Cited: 20
Nika Marđetko, Mitja Kos, Sabine Vogler
Expert Review of Pharmacoeconomics & Outcomes Research (2018) Vol. 19, Iss. 2, pp. 159-179
Closed Access | Times Cited: 20
Long-term effect of tendering on prices of branded pharmaceutical products
Panagiotis Petrou
Health Policy and Technology (2015) Vol. 5, Iss. 1, pp. 40-46
Closed Access | Times Cited: 14
Panagiotis Petrou
Health Policy and Technology (2015) Vol. 5, Iss. 1, pp. 40-46
Closed Access | Times Cited: 14
Pharmaceutical pricing policies in Qatar and Lebanon: narrative review and document analysis
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim, Zaheer‐Ud‐Din Babar
Journal of Pharmaceutical Health Services Research (2019) Vol. 10, Iss. 3, pp. 277-287
Open Access | Times Cited: 11
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim, Zaheer‐Ud‐Din Babar
Journal of Pharmaceutical Health Services Research (2019) Vol. 10, Iss. 3, pp. 277-287
Open Access | Times Cited: 11
Pharmaceutical expenditure dynamics in the Balkan countries
Ana V. Pejčić, Mihajlo Jakovljević
Journal of Medical Economics (2017) Vol. 20, Iss. 10, pp. 1013-1017
Open Access | Times Cited: 10
Ana V. Pejčić, Mihajlo Jakovljević
Journal of Medical Economics (2017) Vol. 20, Iss. 10, pp. 1013-1017
Open Access | Times Cited: 10
The Effects of Cost Containment and Price Policies on Pharmaceutical Expenditure in South Korea
Woohyeon Kim, Heejo Koo, Hye-Jae Lee, et al.
International Journal of Health Policy and Management (2021)
Open Access | Times Cited: 4
Woohyeon Kim, Heejo Koo, Hye-Jae Lee, et al.
International Journal of Health Policy and Management (2021)
Open Access | Times Cited: 4
Medicines Pricing Policy and Strategies in Developing Countries
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim
Elsevier eBooks (2017), pp. 111-128
Closed Access | Times Cited: 1
Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim
Elsevier eBooks (2017), pp. 111-128
Closed Access | Times Cited: 1
PHARMACEUTICAL MARKET OF ANALGESIC MEDICINES IN ROMANIA
Irina Iaru
FARMACIA (2020) Vol. 68, Iss. 5, pp. 938-943
Open Access | Times Cited: 1
Irina Iaru
FARMACIA (2020) Vol. 68, Iss. 5, pp. 938-943
Open Access | Times Cited: 1
Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study
Kyung‐Bok Son, Eui‐Kyung Lee
Family Practice (2021) Vol. 39, Iss. 5, pp. 791-798
Closed Access | Times Cited: 1
Kyung‐Bok Son, Eui‐Kyung Lee
Family Practice (2021) Vol. 39, Iss. 5, pp. 791-798
Closed Access | Times Cited: 1
Availability and procurement of generics in hospitals among medium-sized European countries
Brian Godman
Generics and Biosimilars Initiative Journal (2014) Vol. 3, Iss. 4, pp. 162-163
Open Access
Brian Godman
Generics and Biosimilars Initiative Journal (2014) Vol. 3, Iss. 4, pp. 162-163
Open Access
Pharmaceutical policy interventions in times of economic recession
GaBI Journal Editor
Generics and Biosimilars Initiative Journal (2014) Vol. 3, Iss. 4, pp. 204-204
Open Access
GaBI Journal Editor
Generics and Biosimilars Initiative Journal (2014) Vol. 3, Iss. 4, pp. 204-204
Open Access
TÜRKİYE’DE UYGULANAN İLAÇ POLİTİKALARI KONUSUNDA PAYDAŞLARIN GÖRÜŞ VE TERCİHLERİNİN ÇOK KRİTERLİ KARAR VERME YÖNTEMİ (ELECTRE III) İLE DEĞERLENDİRİLMESİ
Canan DEMİR, Bayram Şahi̇n
Sosyal Guvence (2022), pp. 565-591
Open Access
Canan DEMİR, Bayram Şahi̇n
Sosyal Guvence (2022), pp. 565-591
Open Access
